Cancer Horizons logo
Select a Cancer Type:

Kidney

‘No Stupid Questions’ for Newly Diagnosed Patients With Cancer

News
Video

An expert stressed the importance of finding a patient support group and asking questions after being diagnosed with kidney — or any other form — of cancer.

Finding a patient support group could be essential after being diagnosed with kidney cancer, explained Dr. Rachel Giles, chief executive officer of the International Kidney Cancer Coalition.

In a recent interview, Giles explained that the time after diagnosis can be extremely overwhelming for patients, as they navigate treatment options and side effects. By becoming educated about their disease and joining a group of individuals who have gone through something similar, this burden can be a bit easier to bear, Giles said.

Transcript

It's all about getting the right information. And like I said, the most vulnerable time for a patient is after diagnosis when they have been told that they have cancer, in this case. And (regarding) the choice that they make the treatment that they start, there is a huge amount (of decisions) … often just a few short weeks. And in those that period of time, the patient has to become essentially an expert in their disease condition and figure out all the options plus perhaps what their doctors may not be telling them. So sometimes you have the guidelines that are approved in whatever country you are, and you need to compare that with what the options are, that are being provided, because some hospitals may leave out options. So we try and help that.

But typically, I tell patients to go find a patient organization; this will support you tremendously at all levels. They'll give you information, you'll find a peer-to-peer support system where you'll learn about your condition, and perhaps people can turn you on to ideas you've never even thought about. And also during treatment, of course, this is a very helpful resource because you actually have someone to turn to and say, “I am having a lot of diarrhea,” for example. “What products and what stores do you buy (medications to help) at?” It can be very specific and that's, that's tremendously useful information.

So I would tell patients to take the time to breathe in, breathe out. There's a lot of information out there, it's not impossible, but it is a lot of work, and it's hard to do when you're dealing with the impact of a problem, possibly an out-of-the-blue of a diagnosis.

In the situation of kidney cancer there, it's typically asymptomatic — you have no symptoms whatsoever. And you we found a lot of people, for example, were being diagnosed with the renal masses, as they call them during COVID, because they were going to get their lung CT. And the kidneys are behind the lungs. So that would come up in the imaging. And we had, I think, all the patient organizations in kidney cancer (space) got that huge uptake in phone calls, and requests for support because they didn't know what to do with these small renal masses. You know, we don't know if they're really going to be cancer or not what they are, it could take years before they become anything scary. But no one really knows and there's no guidelines for that.

So the idea is to just find your patient organization, try and find a partner. You know, some people get binders and actually put all the information into one place. Whatever works for you, is convenient, but do take the time to understand the information and ask questions. Don't be scared. There are no wrong answers, no stupid questions. And it's important to be aware that your options are what they are and that they're the right options, that they're guidelines that they're compliant to the guidelines, make sure that you're getting what you should be getting. And but typically, that's not a problem. It's just occasionally and just ask questions.


For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE
Related Content

RELATED ARTICLES

View additional resources on CureToday.com